In her pursuit to improve the lives of people living with cancer, Dr. Rita Rizk is committed to realizing the promise of personalized medicines for cancer. Dr. Rizk seeks to develop targeted therapies in combination with companion diagnostics to better serve patients and ensure the right drug gets to the right patient.
“ We cannot direct the wind but we can adjust the sails ”
“ Out of suffering have emerged the strongest souls; the most massive characters are seared with scars. ” Gibran Khalil Gibran
Biography
About Dr. Rita Rizk
Dr. Rita Rizk graduated from the medical school of "Université Catholique de Louvain" ("UCL") (Brussels - Begium) in June 2006, then followed by her medical degree in Oncology and Internal Medicine from the same university "UCL" in September 2012, both with distinction.
Dr. Rizk completed her emphasis in Oncology - Hematology and Internal Medicine at several hospitals in Belgium and Lebanon; Department of Internal Medicine at Centre Hospitalier Régional Val de Sambre - Belgium, Department of Hematology at Cliniques Sainte Elisabeth - Belgium, Department of Oncology at Cliniques Universitaires Saint Luc - Belgium, and Department of Hematology and Oncology at Centre Hospitalier Universitaire Notre Dame des Secours - Lebanon.
Morevover, she made several publications, one of these publications was: Castrate Resistant Prostate Cancer with Peritoneal Metastasis Treated with Docetaxel-based Chemotherapy - Urology Int. 2013. http://www.ncbi.nlm.nih.gov/pubmed/24296400
Dr. Rizk is currently a practicing oncologist at Bellevue Medical Center - Beirut and Centre Hospitalier Universitaire Notre Dame des Secours - Byblos.